ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ROOTELLA REGISTRATION APPROVED IN CHINA, ARGENTINA, AND SOUTH AFRICA

--News Direct--

Groundwork BioAg® announced that its flagship mycorrhizal inoculant - Rootella® - has been approved for commercialization in China, Argentina, and South Africa, expanding farmers’ access to a climate-smart solution to optimize plant and soil health, adding approximately 677 million acres (274 million hectares) of harvested cropland to the company’s potential customer base.

According to a recent report, chemical crop protection risks have prompted many governments to make a significant shift to biological alternatives. While the agricultural biological global market is projected to increase by more than 13% CAGR by 2028, few biological companies can scale to meet demand. Over the last few years, Groundwork BioAg expanded commercialization in the United States, Brazil, India, Canada, Ukraine, and other countries in Europe. With the addition of China, Argentina, and South Africa, the company and its local partners can offer farmers – including those in four of the top agricultural markets – access to the most highly concentrated mycorrhizal inoculant products available.

“Growers face mounting environmental and financial pressures to produce the food, fuel and fiber the world demands,” said Mr. Hanan Dor, Chief Commercial Officer at Groundwork BioAg. “As the leading mycorrhizal inoculant supplier, Groundwork BioAg is committed to partnering with local distributors to provide nature-based solutions that fit into modern farming practices and align with the world’s sustainability goals.”

Rootella mycorrhizal inoculants are used globally to regenerate agricultural land, sequester carbon, and increase productivity.

Led by its representative office in Hainan province, the company is completing local trials in corn, soybean, wheat, cotton and select specialty crops, and is poised to offer Rootella® to farmers before China’s 2024 planting season. “Based on trial results, we received positive interest from several local distributors, and have immediate sales in 2024,” said Mr. Shu Yang, country manager for Groundwork BioAg - China.

In South Africa, the company is cooperating with AGRivested to support local farmers, starting immediately. The company expects to have a distribution agreement in place in Argentina in 2024.

“To have the greatest impact, we quickly scaled to support the largest agricultural producers as well as millions of smallholders,” said Dor. “With help from mycorrhiza, the Queen of Biologicals™, farmers everywhere can now regenerate their soil, sequester carbon, and ensure a productive and sustainable harvest.”

About Groundwork BioAg

Groundwork BioAg, a global bioagriculture company, leverages the natural power of mycorrhizal fungi to improve the productivity, sustainability and profitability of commercial agriculture and expand regenerative agriculture practices. Groundwork BioAg is the first to use innovative techniques to solve challenges inherent in high-volume mycorrhizal inoculant production. We will not rest until every hectare of arable land is protected by mycorrhizae and every farmer benefits from higher crop yields while preserving our soils. For more information, visit www.groundworkbioag.com.

Contact Details

AgTech PR for Groundwork BioAg

Jennifer Goldston

jennifer@agtechpr.com

Company Website

https://www.groundworkbioag.com

View source version on newsdirect.com: https://newsdirect.com/news/rootella-registration-approved-in-china-argentina-and-south-africa-315938901

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.